Showing results (1061-1070 of 2,284) with videos related to

Sort By:
Pageof 229
HIV Medicine|November 5, 2024
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4-FHDH)S Abgrall, H Selinger-Leneman, E Lanoy, et al.
HIV Medicine|November 7, 2024
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIVMontserrat Laguno, Elisa de Lazzari, Leire Berrocal, et al.
HIV Medicine|December 2, 2024
Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naïve and ART-experienced people with HIV in real-world setting: Data from the Icona cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Eugenia Quiros-Roldan, et al.
HIV Medicine|November 26, 2024
Trends and disparities in antiretroviral therapy prescription rates among US Medicare beneficiaries with HIVXiaoying Yu, Yong-Fang Kuo, Ashley A Dike, et al.
HIV Medicine|March 20, 2025
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor useKathleen J Pincus, Nabila Faridi, Patrick Amadeus Ryscavage, et al.
HIV Medicine|October 25, 2024
Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in SpainRebeca Izquierdo, Inés Suárez-García, Teresa Gómez-García, et al.
HIV Medicine|October 5, 2024
Examining trends in the incidence of HIV infection among people with a history of drug use to inform an outbreak investigation and response: A retrospective cohort studyKirsten M A Trayner, Norah E Palmateer, Andrew McAuley, et al.
HIV Medicine|July 31, 2024
Characterizing heart failure and its subtypes in people living with HIVKarla Inestroza, Vanessa Hurtado, Michaela E Larson, et al.
HIV Medicine|August 13, 2024
No increased risk of tuberculosis-related immune reconstitution inflammatory syndrome with integrase inhibitor-based antiretroviral therapy in people with HIV with profound immunosuppressionChi Kuen Chan, Shan Shan Huang, Ka Hing Wong, et al.
HIV Medicine|September 5, 2024
Therapeutic failure reported with HIV long-acting injectables: An analysis of the FDA Adverse Event Reporting System from 2021 to 2024Kenneth L McCall, Danielle L Cabral, Jamie F Coghlan, et al.
Pageof 229